News
Lawyer Monthly – Transaction of the month: Lactalis acquires Albalact
Leroy și Asociații advised Lactalis on acquisition of Albalact minority stakes
This follows the assistance provided to the French group regarding the voluntary public takeover bid of Albalact. Leroy şi Asociaţii advised the French group Lactalis on the procedure of withdrawal of the minority shareholders of Albalact (squeeze out). This procedure successfully completed the largest transaction of the past five years in the FMCG industry, resulting
Bruno Leroy: Investment funds are taking a closer look at Romania, especially at companies in the banking and energy sectors.
Currently this article is only available in Romanian.
Lawyer Monthly – Legal Awards 2016: Leroy şi Asociatii was awarded the “Antitrust & Competition Law Firm of the Year” title by the international publication Lawyer Monthly.
Leroy și Asociații is the exclusive legal advisor to Yves Rocher on the acquisition of Cosmetique de France
Leroy şi Asociaţii is the exclusive legal advisor to French group Yves Rocher on the acquisition of 100% of the share capital of Cosmetiques de France, owner of the Yves Rocher franchise in Romania, operating 40 stores. Click here to read the full brief.
Bruno Leroy, lawyer: Romanian entrepreneurs prefer to sell their business and start over, rather than developing it into a regional business.
Currently this article is only available in Romanian.
Leroy şi Asociaţii counsels IFC on the MedLife listing on the Bucharest Stock Exchange
The independent law firm advises the International Finance Corporation (IFC), the investment division of the World Bank, on the listing of a minority MedLife stake on the Bucharest Stock Exchange.
Leroy și Asociații is the exclusive legal advisor to the International Finance Corporation in relation to the refinancing of the loan granted by BCR to MEDLIFE group
Leroy şi Asociaţii is exclusive legal advisor to the International Finance Corporation on all legal matters in connection to the refinancing by a pool of lenders of the loan granted by BCR to Med Life group companies.